We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
-5.6%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$52.9M
AUM Growth
+$8.05M
Cap. Flow
-$1.01M
Cap. Flow %
-1.9%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RCKT icon
Rocket Pharmaceuticals
RCKT
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PASG icon
1
Passage Bio
PASG
$15.7M
$20M 37.74%
124,896
EWTX icon
2
Edgewise Therapeutics
EWTX
$4.35B
$13.5M 25.51%
1,030,161
ARVN icon
3
Arvinas
ARVN
$524M
$11.7M 22.04%
1,585,721
CRNX icon
4
Crinetics Pharmaceuticals
CRNX
$8.87B
$4.06M 7.66%
141,000
COGT icon
5
Cogent Biosciences
COGT
$6.75B
$1.8M 3.4%
250,765
RLYB icon
6
Rallybio
RLYB
$86.8M
$1.12M 2.11%
412,700
ALEC icon
7
Alector
ALEC
$167M
$475K 0.9%
339,569
ITRM
8
DELISTED
Iterum Therapeutics
ITRM
$343K 0.65%
345,020
RCKT icon
9
Rocket Pharmaceuticals
RCKT
$353M
-150,706
Closed -$1.01M

Similar funds

New Leaf Venture Partners's Q2 2025 Portfolio in Review

As of Q2 2025, New Leaf Venture Partners held 9 positions worth $52.9M, up 18% from $44.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

New Leaf Venture Partners's Q2 2025 filing shows 1 closed position. The largest sale was Rocket Pharmaceuticals, an estimated $1.01M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • New Leaf Venture Partners fully exited Rocket Pharmaceuticals in Q2 2025, selling an estimated $1.01M.
  • New Leaf Venture Partners's ten largest holdings make up 100% of its $52.9M portfolio in Q2 2025.
  • New Leaf Venture Partners opened 0 new positions and closed 1 in Q2 2025.
  • New Leaf Venture Partners's portfolio value rose 18% quarter-over-quarter to $52.9M.

Based on New Leaf Venture Partners's 13F filing for Q2 2025, filed 13 Aug 2025.